Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-05 1:52 pm Unchanged |
2020-12-31 | 13G | Bellerophon Therapeutics, Inc. BLPH |
SABBY MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-01-05 1:45 pm Unchanged |
2020-12-31 | 13G | Titan Medical Inc. TMDIF |
SABBY MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-01-05 12:18 pm Purchase |
2020-12-31 | 13G | Helius Medical Technologies, Inc. HSDT |
SABBY MANAGEMENT LLC | 51,852 11.000% |
51,852 (New Position) |
Filing History |
| 2021-01-05 11:45 am Purchase |
2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
SABBY MANAGEMENT LLC | 14,614,140 11.000% |
14,614,140 (New Position) |
Filing History |
| 2021-01-05 11:03 am Purchase |
2020-12-31 | 13G | Asensus Surgical, Inc. ASXC |
SABBY MANAGEMENT LLC | 4,985,523 11.000% |
607,106 (+13.87%) |
Filing History |
| 2021-01-05 10:50 am Purchase |
2020-12-31 | 13G | Biocept, Inc. BIOC |
SABBY MANAGEMENT LLC | 6,439 11.000% |
6,439 (New Position) |
Filing History |
| 2021-01-05 10:06 am Sale |
2020-12-31 | 13G | Novan, Inc. NOVN |
SABBY MANAGEMENT LLC | 0 0.000% |
-333,333 (Position Closed) |
Filing History |
| 2021-01-05 09:26 am Sale |
2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP |
SABBY MANAGEMENT LLC | 0 0.000% |
-288,462 (Position Closed) |
Filing History |
| 2021-01-05 09:20 am Sale |
2020-12-31 | 13G | Lipocine Inc. LPCN |
SABBY MANAGEMENT LLC | 0 0.000% |
-197,726 (Position Closed) |
Filing History |
| 2021-01-05 08:55 am Sale |
2020-12-31 | 13G | Outlook Therapeutics, Inc. OTLK |
SABBY MANAGEMENT LLC | 81,253 11.000% |
-66,385 (-44.96%) |
Filing History |
| 2021-01-05 08:39 am Purchase |
2020-12-31 | 13G | LIANLUO SMART LTD LLIT |
SABBY MANAGEMENT LLC | 179,619 11.000% |
179,619 (New Position) |
Filing History |
| 2021-01-05 08:20 am Purchase |
2020-12-31 | 13G | ZOMEDICA CORP COM ZOMDF |
SABBY MANAGEMENT LLC | 12,633,334 11.000% |
12,633,334 (New Position) |
Filing History |
| 2021-01-05 07:58 am Sale |
2020-12-31 | 13G | Zosano Pharma Corporation ZSAN |
SABBY MANAGEMENT LLC | 0 0.000% |
-102,185 (Position Closed) |
Filing History |
| 2021-01-05 07:45 am Purchase |
2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
SABBY MANAGEMENT LLC | 2,671 11.000% |
951 (+55.33%) |
Filing History |
| 2021-01-04 6:42 pm Sale |
2020-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP |
SABBY MANAGEMENT LLC | 0 11.000% |
-2 (-91.91%) |
Filing History |
| 2021-01-04 3:43 pm Purchase |
2020-12-31 | 13G | ReWalk Robotics Ltd. LFWD |
SABBY MANAGEMENT LLC | 176,484 11.000% |
176,484 (New Position) |
Filing History |
| 2021-01-04 2:02 pm Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
SABBY MANAGEMENT LLC | 34,633 11.000% |
-7,034 (-16.88%) |
Filing History |
| 2021-01-04 1:40 pm Purchase |
2020-12-31 | 13G | Intec Pharma Ltd NTEC |
SABBY MANAGEMENT LLC | 49,254 11.000% |
49,254 (New Position) |
Filing History |
| 2021-01-04 12:21 pm Purchase |
2020-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
SABBY MANAGEMENT LLC | 103 11.000% |
103 (New Position) |
Filing History |
| 2021-01-04 11:58 am Sale |
2020-12-31 | 13G | Co-Diagnostics, Inc. CODX |
SABBY MANAGEMENT LLC | 0 0.000% |
-1,379,311 (Position Closed) |
Filing History |